A Study of Real-World Outcomes of People With Crohn's Disease (CD)

CompletedOBSERVATIONAL
Enrollment

623

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Crohn Disease
Trial Locations (31)

1000

CHU St-Pierre, Brussels

1070

Hopital Erasme, Anderlecht

2139

Concord Repatriation General Hospital, Concord

2170

Liverpool Hospital, Liverpool

2305

John Hunter Hospital, New Lambton

2650

UZ Antwerpen, Edegem

2820

Imelda VZW, Bonheiden

3000

Royal Melbourne Hospital, East Melbourne

UZ Leuven, Leuven

3004

The Alfred Hospital, Melbourne

3010

Inselspital Bern, Bern

3012

Intesto KLG Gastroenterologische Praxis Crohn-Colitis-Zentrum, Bern

3168

Monash Health, Monash Medical Centre, Clayton

4000

Centre Hospitalier Chretien MontLegia, Liège

CHU de Liege, Liège

4029

Royal Brisbane & Women's Hospital, Herston

4051

Clarunis Bauchzenturm, Basel

4068

Integrated Gut Health Pty Ltd, Taringa

4101

Mater Misericordiae Health Services, South Brisbane

5000

Royal Adelaide Hospital, Adelaide

5112

Lyell McEwin Hospital, Elizabeth Vale

6008

St John of God Hospital Subiaco, Subiaco

6150

Fiona Stanley Hospital, Murdoch

7000

Centre Hospitalier Universitaire Ambroise Pare, Mons

7500

CHWAPI Tournai, Tournai

8063

Stadtspital Triemli Zurich, Zurich

8091

Universitatsspital Zurich, Zurich

8500

AZ Groeninge, Kortrijk

8800

AZ Delta, Roeselare

9000

AZ Sint-Lucas, Ghent

UZ Gent, Ghent

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT05056441 - A Study of Real-World Outcomes of People With Crohn's Disease (CD) | Biotech Hunter | Biotech Hunter